Development Level

Tbio 5 | 10,625
Tchem 2 | 1,890
Tclin 1 | 602

IMPC Term

decreased blood urea nitrogen ... 1 | 31
preweaning lethality, complete... 1 | 633

Disease

psoriasis 6 | 6,685
Alcohol dependence 5 | 107
Anxiety Disorders 5 | 37
Cocaine-Related Disorders 5 | 88
Anorexia 4 | 15
Cancer 4 | 2,346
Irritable bowel syndrome 4 | 59
Major Depressive Disorder 4 | 106
Obesity 4 | 616
chronic kidney disease 4 | 90
glioblastoma 4 | 5,572
medulloblastoma, large-cell 4 | 6,234
pilocytic astrocytoma 4 | 3,086
post-traumatic stress disorder 4 | 45
Alzheimer's disease 3 | 644
Epilepsy 3 | 346
Hyperactive behavior 3 | 31
Hypertension 3 | 287
Panic disorder 3 | 55
Pick disease 3 | 1,893
atypical teratoid / rhabdoid tumor 3 | 4,369
diabetes mellitus 3 | 1,663
osteosarcoma 3 | 7,933
pediatric high grade glioma 3 | 2,712
primitive neuroectodermal tumor 3 | 3,031
Alcoholic Intoxication, Chronic 2 | 41
Anorexia nervosa 2 | 59
Asthma 2 | 349
Depressive disorder 2 | 48
Fibromyalgia 2 | 22
Generalized anxiety disorder 2 | 29
Heart disease 2 | 279
Huntington's disease 2 | 72
Hypoglycemia 2 | 81
IGA Glomerulonephritis 2 | 454
Migraine 2 | 79
Osteoporosis 2 | 257
Pain agnosia 2 | 99
Parkinson Disease 2 | 102
Rhinitis 2 | 46
Schizophrenia 2 | 501
Seizures 2 | 95
Substance Withdrawal Syndrome 2 | 52
Substance abuse 2 | 55
Weight decreased 2 | 18
Withdrawal disorder 2 | 19
astrocytoma 2 | 1,493
ependymoma 2 | 2,514
group 3 medulloblastoma 2 | 2,254
lung cancer 2 | 4,466
oligodendroglioma 2 | 2,849
ovarian cancer 2 | 8,484
posterior fossa group A ependymoma 2 | 1,511
tuberculosis 2 | 1,557
ulcerative colitis 2 | 2,087
Acute Lung Injury 1 | 18
Adenocarcinoma 1 | 115
Adrenal adenoma 1 | 5
Adverse reaction to drug 1 | 54
Amenorrhea 1 | 60
Atypical depressive disorder 1 | 6
Bipolar Disorder 1 | 266
Bradycardia 1 | 24
Bronchitis, Chronic 1 | 9
Bulimia nervosa 1 | 15
Cardiomegaly 1 | 66
Complex regional pain syndrome 1 | 12
Drug Eruptions 1 | 18
Drug-Induced Liver Injury 1 | 118
Eating disorder 1 | 24
Epicondylitis 1 | 19
Fatty Liver 1 | 48
Fatty liver disease 1 | 84
Gastrointestinal system disease 1 | 50
Glioma 1 | 65
Hepatitis C 1 | 90
Hyperglycemia 1 | 120
Hypopituitarism 1 | 36
Hypotension 1 | 53
Liver Neoplasms, Experimental 1 | 48
Liver disease 1 | 219
Lung Neoplasms 1 | 171
Lung diseases 1 | 48
Lupus erythematosus 1 | 80
Lymphoma, Non-Hodgkin 1 | 22
Mammary Neoplasms 1 | 410
Melancholia 1 | 12
Muscle Rigidity 1 | 5
Narcolepsy 1 | 58
Necrosis 1 | 51
Neoplasm Invasiveness 1 | 127
Nicotine dependence 1 | 53
Pain 1 | 70
Periodontal disease 1 | 37
Phaeochromocytoma 1 | 20
Stereotypic movement disorder 1 | 6
Tularemia 1 | 22
West Syndrome 1 | 23
fascioscapulohumeral muscular dystrophy 1 | 100
sarcoidosis 1 | 358

Tissue

Endocrine System 8 | 18,512
Female tissues 8 | 18,647
Nervous System 8 | 18,561
Cardiovascular System 7 | 17,958
Digestive Tract 7 | 18,473
Liver and Pancreas 7 | 18,136
Male tissues 7 | 17,969
Respiratory system 7 | 17,484
Skin and soft tissues 7 | 18,115
Urinary Tract 7 | 18,444
Blood and immune system 6 | 17,995

Target Family

Non-IDG 5 | 11,971
GPCR 2 | 406
Kinase 1 | 634

Grant Application

5P60AA006420-23 8 | 8
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Pro-neuropeptide Y NPY Tbio Non-IDG -3.81741 7285.3 401
Interferon-inducible protein AIM2 AIM2 Tbio Non-IDG -2.26799 140.7 401
Neuropeptide S NPS Tchem Non-IDG -3.89942 7090.5 86
Corticotropin-releasing factor receptor 1 CRHR1 Tclin GPCR -2.86480 704.2 314
Activin receptor type-1 ACVR1 Tchem Kinase -2.39398 253.5 392
Corticoliberin CRH Tbio Non-IDG -3.72173 5615.4 346
Corticotropin-releasing factor receptor 2 CRHR2 Tbio GPCR -2.42203 247.7 367
Cytochrome P450 2E1 CYP2E1 Tbio Non-IDG -3.38706 2573.0 350